Table 1 Details of antibodies/techniques used

From: Assessing proliferation, cell-cycle arrest and apoptotic end points in human buccal punch biopsies for use as pharmacodynamic biomarkers in drug development

Target

Supplier

Host/type

Catalogue number

Dilution

Detection System

Total-pRb

CST

Mouse monoclonal

9309

1 : 100

Mouse Envision+

Phospho(S249/T252)-pRb

Biosource

Rabbit polyclonal

44-584

1 : 1000

Rabbit Envision+

Total-p27

RDI

Rabbit polyclonal

P27CabrX

1 : 100

Rabbit Envision+

Phospho(T187)-p27

Upstate

Rabbit polyclonal

06-996

1 : 100

Rabbit Envision+

p53

NovoCastra

Rabbit polyclonal

NCL-p53-CM1

1 : 2500

Rabbit Envision+

Cyclin A

Neomarkers

Mouse monoclonal

MS-1061S1

1 : 40

Mouse Envision+

Cyclin E

NovoCastra

Mouse monoclonal

NCL-CYCLIN E

1 : 20

Mouse Envision+

Ki67

Dako

Mouse monoclonal

M7240

1 : 25

Mouse Envision+

Phospho(S10)-Histone H3

Upstate

Rabbit polyclonal

06–570

1 : 1000

Rabbit Envision+

p21

BD Pharmingen

Mouse monoclonal

610234

1 : 25

Mouse Envision+

Cleaved-Caspase-3

CST

Rabbit polyclonal

9661

1 : 300

Rabbit Envision+

M30

Roche

Mouse monoclonal

2 140 349

1 : 200

Mouse Envision+

TUNEL (in situ cell death kit)

Roche

N/A

1 684 817

  
  1. pRb=phosphorylated pRb; phospho-p27=phosphorylated p27; TUNEL=terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling.
  2. CST–New England Biolabs (UK) Ltd, Hitchin, Hertfordshire, UK; Biosource–B-1400 Nivelles, Belgium; RDI–Concord MA 01742-3049 USA; Upstate–Dundee, UK; Novocastra–Newcastle upon Tyne, UK; Neomarkers–Lab Vision (UK) Ltd, Newmarket, Suffolk, UK; Dako–Ely, Cambridgeshire, UK; BD Pharmingen–Cowley, Oxford, UK.